Absci (ABSI) Receivables (2020 - 2026)
Absci (ABSI) reported Receivables of $100000.0 for Q1 2026, down 92.77% on a YoY basis from $1.4 million in Q1 2025, and down 90.0% sequentially from $1.0 million in Q3 2025.
Absci (ABSI) Receivables (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Receivables data on file, last reported at $100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables fell 92.77% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $100000.0 (down 92.77% YoY), and the FY2023 full-year result was $2.2 million, up 41.23% from the prior year.
- Receivables slipped to $100000.0 in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $3.2 million in Q2 2023 to a low of $42000.0 in Q1 2024.
- A 5-year average of $977466.7 and a median of $800000.0 in 2023 frame the typical range for Receivables.
- Across the five-year window, Receivables sank 98.61% in 2024 and surged 3195.24% in 2025, its largest moves.
- Tracing ABSI's Receivables over 5 years: stood at $1.5 million in 2022, then jumped by 41.23% to $2.2 million in 2023, then sank by 31.48% to $1.5 million in 2024, then sank by 33.33% to $1.0 million in 2025, then slumped by 90.0% to $100000.0 in 2026.
- Business Quant data shows ABSI's Receivables at $100000.0 in Q1 2026, $1.0 million in Q3 2025, and $700000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 1.38 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 2.19 Mn |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 3.16 Mn |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | 1.55 Mn |
| Sep 30, 2022 | 210,000.00 |
| Jun 30, 2022 | 310,000.00 |
| Mar 31, 2022 | 350,000.00 |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 714,000.00 |
| Jun 30, 2021 | 545,000.00 |
| Dec 31, 2020 | 100,000.00 |